1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 130 of 630 | 2160 prescriptions Less than 1% of all prescriptions | 1550 | 520 patients 13% of all patients | 370 patients 9% of all patients | |
2 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 80 of 590 | 2000 prescriptions Less than 1% of all prescriptions | 1650 | 450 patients 11% of all patients | < 11 | |
3 VENTOLIN HFA (ALBUTEROL SULFATE) | 200 of 700 | 2200 prescriptions Less than 1% of all prescriptions | 1260 | 750 patients 19% of all patients | 480 patients 12% of all patients | |
4 MONTELUKAST SODIUM | 270 of 610 | 1100 prescriptions Less than 1% of all prescriptions | 740 | 260 patients 6% of all patients | 130 patients 3% of all patients | |
5 PREDNISONE | 200 of 670 | 1660 prescriptions Less than 1% of all prescriptions | 1270 | 910 patients 23% of all patients | 580 patients 14% of all patients | |
6 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 180 of 590 | 1160 prescriptions Less than 1% of all prescriptions | 990 | 220 patients 6% of all patients | < 11 | |
7 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 380 of 650 | 950 prescriptions Less than 1% of all prescriptions | 750 | 270 patients 7% of all patients | < 11 | |
8 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 240 of 630 | 700 prescriptions Less than 1% of all prescriptions | 510 | 180 patients 4% of all patients | < 11 | |
9 SPIRIVA (TIOTROPIUM BROMIDE) | 170 of 520 | 670 prescriptions Less than 1% of all prescriptions | 460 | 190 patients 5% of all patients | < 11 | |
10 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 40 of 350 | 580 prescriptions Less than 1% of all prescriptions | 450 | 160 patients 4% of all patients | < 11 | |
11 FAMOTIDINE | 30 of 80 | 520 prescriptions Less than 1% of all prescriptions | 300 | 200 patients 5% of all patients | < 11 | |
12 FLUTICASONE PROPIONATE | 220 of 580 | 590 prescriptions Less than 1% of all prescriptions | 430 | 280 patients 7% of all patients | 170 patients 4% of all patients | |
13 OMEPRAZOLE | 130 of 380 | 460 prescriptions Less than 1% of all prescriptions | 180 | 160 patients 4% of all patients | < 11 | |
14 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 130 of 460 | 580 prescriptions Less than 1% of all prescriptions | 220 | 150 patients 4% of all patients | < 11 | |
15 RANITIDINE HCL | 60 of 150 | 430 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
16 DALIRESP (ROFLUMILAST) | 230 of 380 | 270 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
17 ROPINIROLE HCL | 60 of 190 | 310 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
18 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 200 of 450 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 MOMETASONE FUROATE | 10 of 20 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 GABAPENTIN | 80 of 120 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 ZOLPIDEM TARTRATE | 100 of 220 | 290 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
22 PROAIR HFA (ALBUTEROL SULFATE) | 220 of 500 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 FUROSEMIDE | 160 of 320 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 AZITHROMYCIN | 210 of 540 | 430 prescriptions Less than 1% of all prescriptions | 290 | 390 patients 10% of all patients | 260 patients 6% of all patients | A |
25 DESLORATADINE | 10 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
26 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 80 of 300 | 420 prescriptions Less than 1% of all prescriptions | | 370 patients 9% of all patients | < 11 | A |
27 METHOTREXATE (METHOTREXATE SODIUM) | 40 of 50 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 LETAIRIS (AMBRISENTAN) | 100 of 150 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
29 METHYLPHENIDATE HCL | 50 of 50 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 THEO-24 (THEOPHYLLINE ANHYDROUS) | 40 of 50 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
31 VENLAFAXINE HCL ER (VENLAFAXINE HCL) | 20 of 40 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
32 ESZOPICLONE | 30 of 50 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
33 AZELASTINE HCL | 100 of 120 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
34 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 170 of 230 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
35 CLONAZEPAM | 170 of 210 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
36 DEXILANT (DEXLANSOPRAZOLE) | 30 of 30 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
37 MELOXICAM | 40 of 40 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
38 MODAFINIL | 70 of 80 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
39 SERTRALINE HCL | 70 of 70 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
40 TEMAZEPAM | 70 of 100 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
41 VALSARTAN-HYDROCHLOROTHIAZIDE (VALSARTAN/HYDROCHLOROTHIAZIDE) | 30 of 30 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
42 ALPRAZOLAM | 120 of 170 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
43 LEVOFLOXACIN | 120 of 370 | 340 prescriptions Less than 1% of all prescriptions | 200 | 290 patients 7% of all patients | < 11 | A |
44 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 130 of 170 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
45 CIPROFLOXACIN HCL | 140 of 180 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |